BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33917187)

  • 1. Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB
    Asproni B; Murineddu G; Corona P; Pinna GA
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
    J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties.
    Deiana V; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Asproni B; Cichero E; Fossa P; Muñoz E; Deligia F; Murineddu G; García-Arencibia M; Pinna GA
    Eur J Med Chem; 2016 Apr; 112():66-80. PubMed ID: 26890113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pyrrolocycloalkylpyrazole analogues as CB
    Asproni B; Manca I; Pinna G; Cichero E; Fossa P; Murineddu G; Lazzari P; Loriga G; Pinna GA
    Chem Biol Drug Des; 2018 Jan; 91(1):181-193. PubMed ID: 28675787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.
    Ji B; Liu S; He X; Man VH; Xie XQ; Wang J
    ACS Chem Neurosci; 2020 Apr; 11(8):1139-1158. PubMed ID: 32196303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
    Ashton JC; Wright JL; McPartland JM; Tyndall JD
    Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.
    Pinna G; Loriga G; Lazzari P; Ruiu S; Falzoi M; Frau S; Pau A; Murineddu G; Asproni B; Pinna GA
    Eur J Med Chem; 2014 Jul; 82():281-92. PubMed ID: 24922543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.
    Dixon DD; Tius MA; Thakur GA; Zhou H; Bowman AL; Shukla VG; Peng Y; Makriyannis A
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5322-5. PubMed ID: 22796181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonists.
    Chu CM; Hung MS; Hsieh MT; Kuo CW; Suja TD; Song JS; Chiu HH; Chao YS; Shia KS
    Org Biomol Chem; 2008 Sep; 6(18):3399-407. PubMed ID: 18802648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand.
    Seo HJ; Kim MJ; Lee SH; Lee SH; Jung ME; Kim MS; Ahn K; Kim J; Lee J
    Bioorg Med Chem; 2010 Feb; 18(3):1149-62. PubMed ID: 20045337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptors.
    Durdagi S; Reis H; Papadopoulos MG; Mavromoustakos T
    Bioorg Med Chem; 2008 Aug; 16(15):7377-87. PubMed ID: 18595717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastering tricyclic ring systems for desirable functional cannabinoid activity.
    Petrov RR; Knight L; Chen SR; Wager-Miller J; McDaniel SW; Diaz F; Barth F; Pan HL; Mackie K; Cavasotto CN; Diaz P
    Eur J Med Chem; 2013 Nov; 69():881-907. PubMed ID: 24125850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR/CoMFA-based structure-affinity/selectivity relationships of aminoalkylindoles in the cannabinoid CB1 and CB2 receptors.
    Mella-Raipán J; Hernández-Pino S; Morales-Verdejo C; Pessoa-Mahana D
    Molecules; 2014 Mar; 19(3):2842-61. PubMed ID: 24603555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors.
    Reggio PH
    Curr Pharm Des; 2003; 9(20):1607-33. PubMed ID: 12871061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
    Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening.
    Moaddel R; Rosenberg A; Spelman K; Frazier J; Frazier C; Nocerino S; Brizzi A; Mugnaini C; Wainer IW
    Anal Biochem; 2011 May; 412(1):85-91. PubMed ID: 21215722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.
    Zhou H; Peng X; Hou T; Zhao N; Qiu M; Zhang X; Liang X
    J Ethnopharmacol; 2020 Jan; 246():112218. PubMed ID: 31494202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G
    Hua T; Li X; Wu L; Iliopoulos-Tsoutsouvas C; Wang Y; Wu M; Shen L; Brust CA; Nikas SP; Song F; Song X; Yuan S; Sun Q; Wu Y; Jiang S; Grim TW; Benchama O; Stahl EL; Zvonok N; Zhao S; Bohn LM; Makriyannis A; Liu ZJ
    Cell; 2020 Feb; 180(4):655-665.e18. PubMed ID: 32004463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzimidazole derivatives as selective CB2 agonists.
    Pagé D; Balaux E; Boisvert L; Liu Z; Milburn C; Tremblay M; Wei Z; Woo S; Luo X; Cheng YX; Yang H; Srivastava S; Zhou F; Brown W; Tomaszewski M; Walpole C; Hodzic L; St-Onge S; Godbout C; Salois D; Payza K
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3695-700. PubMed ID: 18522867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.